Unmet rehabiliation needs in 86% of Norwegian paediatric embryonal brain tumour survivors
| Autor: | Kristine Stadskleiv, Anne Grete Bechensteen, Petter Brandal, Tor Åge Myklebust, Einar Stensvold, Finn Wesenberg, Eirik Helseth |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Pediatrics
medicine.medical_specialty medicine.medical_treatment 03 medical and health sciences Epilepsy 0302 clinical medicine Ototoxicity 030225 pediatrics Medicine Humans 030212 general & internal medicine Survivors Cerebellar Neoplasms Child Medulloblastoma Chemotherapy Rehabilitation business.industry Brain Neoplasms Norway Incidence (epidemiology) General Medicine medicine.disease Radiation therapy Pediatrics Perinatology and Child Health Cohort business |
| ISSN: | 0803-5253 |
| Popis: | Aim To study incidence, types and degrees of late effects in a geographical cohort of paediatric medulloblastoma and central nervous system primitive neuroectodermal tumour (CNS-PNET) survivors, and identify the need for rehabilitation. Methods Between 1974 and 2013, 63 patients survived treatment for paediatric medulloblastoma and CNS-PNET at Oslo University Hospital, Norway. Of these, 50 accepted invitation and were included in this study. Results Median follow-up was 20 years (range 3.2-41), and 96% of participants had developed late effects. Cognitive impairment was found in 72%, reduced hearing in 68%, endocrine deficits in 66%, epilepsy in 32% and another 30% had been diagnosed with one or more second primary neoplasms. Radiotherapy significantly increased risk of secondary primary neoplasms and endocrinological deficits, chemotherapy risk of ototoxicity and endocrinological deficits, and epilepsy was found significantly more often in CNS-PNET than medulloblastoma patients. Epilepsy was the main cause of cognitive impairments (full-scale IQ) in our study. 86% of participants had an unmet rehabilitation need. Conclusion Significant late effects and unmet rehabilitation needs were documented in the large majority of survivors after treatment for paediatric medulloblastoma and CNS-PNET. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text